ArticleScientific reports2026
The effect of pentacyclic triterpene-NIR-AIE derivatives on the proliferation, migration and apoptosis of Melanoma cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study evaluated the in vitro effects of two pentacyclic triterpene-based near-infrared aggregation-induced emission (NIR-AIE) derivatives, BA-1 and BA-3, on human A375 and murine B16F0 melanoma cell lines. Cell viability was assessed using CCK-8 assays and live/dead staining under both dark conditions and white light irradiation. Scratch-wound healing and Transwell assays were performed to examine cell migration and invasion capabilities. Intracellular reactive oxygen species (ROS) levels were measured using the DCFH-DA probe. Protein expression related to cell proliferation, apoptosis, and invasion was analyzed by Western blotting. The results showed that BA-1 and BA-3 reduced the viability of melanoma cells, with an enhanced effect observed under light exposure. Both compounds also inhibited cell migration and invasion, increased intracellular ROS levels, and regulated apoptosis-related proteins, including downregulation of Bcl-2 and upregulation of Bax, cleaved caspase-3, and cleaved caspase-9. Additionally, the expression of proliferation markers PCNA and C-MYC, as well as the invasion-associated protein MMP2, was reduced. These findings suggest that the tested pentacyclic triterpene-NIR-AIE derivatives may influence melanoma cell growth, motility, and apoptosis through a ROS-associated mitochondrial pathway, highlighting their potential as theranostic agents for targeted chemo-photodynamic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.